Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prunus speciosa flower extract (specifically Fresh Prunus speciosa Flower Extract, or FPSFE) is a botanical extract obtained from the flowers of *Prunus speciosa* (cherry blossom). Developed by Hua An Tang Biotech Group, it is formulated as a topical scalp serum designed to manage sensitive scalp conditions and hair loss. FPSFE exhibits antioxidant, anti-inflammatory, photoprotective, and 5α-reductase inhibitory activities. In vitro, it reduces blue-light-induced reactive oxygen species (ROS) accumulation and apoptosis, decreases inflammatory cytokines (TNF-α and IL-1β), and inhibits 5α-reductase activity. Clinically, topical application of FPSFE-containing serum has been shown to reduce hair shedding, increase hair density, decrease scalp sebum levels, and improve scalp sensitivity and discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prunus speciosa flower extract.